Schonfeld Strategic Advisors LLC Dexcom Inc Transaction History

Schonfeld Strategic Advisors LLC

$14.6 Billion
Q2 2024

A detailed history of Schonfeld Strategic Advisors LLC transactions in Dexcom Inc stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 64,946 shares of DXCM stock, worth $4.75 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

64,946

Previous 59,042 10.0%

Holding current value

$4.75 Million

Previous $8.19 Million 10.09%

% of portfolio

0.05%

Previous 0.06%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$110.31 - $140.45 $651,270 - $829,216	5,904 Added 10.0%	64,946 $7.36 Million
Q1 2024 May 15, 2024	SELL	$114.22 - $140.1 $2.27 Million - $2.78 Million	-19,841 Reduced 25.15%	59,042 $8.19 Million
Q4 2023 Feb 14, 2024	SELL	$75.49 - $124.16 $17 Million - $27.9 Million	-224,764 Reduced 74.02%	78,883 $9.79 Million
Q3 2023 Nov 14, 2023	BUY	$86.06 - $137.93 $19.6 Million - $31.4 Million	227,445 Added 298.48%	303,647 $28.3 Million
Q2 2023 Aug 14, 2023	SELL	$112.47 - $130.98 $1.73 Million - $2.01 Million	-15,338 Reduced 16.76%	76,202 $9.79 Million
Q1 2023 May 15, 2023	BUY	$104.0 - $122.92 $3.4 Million - $4.02 Million	32,739 Added 55.68%	91,540 $10.6 Million
Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $3.45 Million - $4.98 Million	40,601 Added 223.08%	58,801 $6.66 Million
Q3 2022 Nov 14, 2022	SELL	$76.35 - $94.18 $3.5 Million - $4.32 Million	-45,860 Reduced 71.59%	18,200 $1.47 Million
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $3.68 Million - $7.19 Million	54,129 Added 545.05%	64,060 $4.77 Million
Q1 2022 May 16, 2022	SELL	$94.08 - $130.2 $974,198 - $1.35 Million	-10,355 Reduced 51.05%	9,931 $5.08 Million
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $1.02 Million - $1.28 Million	7,838 Added 62.97%	20,286 $10.9 Million
Q3 2021 Nov 16, 2021	BUY	$106.71 - $143.18 $798,831 - $1.07 Million	7,486 Added 150.87%	12,448 $6.81 Million
Q2 2021 Aug 16, 2021	BUY	$80.99 - $107.93 $231,793 - $308,895	2,862 Added 136.29%	4,962 $2.12 Million
Q1 2021 May 17, 2021	SELL	$84.79 - $104.74 $856,379 - $1.06 Million	-10,100 Reduced 82.79%	2,100 $755,000
Q4 2020 Feb 16, 2021	BUY	$78.0 - $104.5 $850,200 - $1.14 Million	10,900 Added 838.46%	12,200 $4.51 Million
Q3 2020 Nov 16, 2020	SELL	$95.51 - $112.95 $1.02 Million - $1.2 Million	-10,634 Reduced 89.11%	1,300 $536,000
Q2 2020 Aug 14, 2020	BUY	$62.68 - $105.34 $428,355 - $719,893	6,834 Added 134.0%	11,934 $4.84 Million
Q1 2020 May 15, 2020	SELL	$47.79 - $75.63 $34,217 - $54,151	-716 Reduced 12.31%	5,100 $1.37 Million
Q4 2019 Feb 14, 2020	SELL	$36.62 - $57.29 $753,822 - $1.18 Million	-20,585 Reduced 77.97%	5,816 $1.27 Million
Q3 2019 Nov 14, 2019	BUY	$35.53 - $43.8 $465,478 - $573,823	13,101 Added 98.5%	26,401 $3.94 Million
Q2 2019 Aug 14, 2019	SELL	$27.84 - $38.92 $1.73 Million - $2.42 Million	-62,100 Reduced 82.36%	13,300 $1.99 Million
Q1 2019 May 15, 2019	BUY	$28.07 - $38.18 $976,836 - $1.33 Million	34,800 Added 85.71%	75,400 $8.98 Million
Q4 2018 Feb 14, 2019	BUY	$26.99 - $37.37 $99,863 - $138,269	3,700 Added 10.03%	40,600 $4.86 Million
Q3 2018 Nov 14, 2018	BUY	$23.35 - $36.72 $665,241 - $1.05 Million	28,490 Added 338.76%	36,900 $5.28 Million
Q2 2018 Aug 14, 2018	SELL	$17.54 - $25.22 $402,946 - $579,379	-22,973 Reduced 73.2%	8,410 $799,000
Q1 2018 May 15, 2018	SELL	$13.06 - $18.54 $1.3 Million - $1.84 Million	-99,447 Reduced 76.01%	31,383 $2.33 Million
Q4 2017 Feb 14, 2018	BUY	$11.12 - $15.38 $380,748 - $526,611	34,240 Added 35.45%	130,830 $7.51 Million
Q3 2017 Nov 14, 2017	BUY	$11.36 - $18.98 $1.1 Million - $1.83 Million	96,590	96,590 $4.73 Million

Others Institutions Holding DXCM

# of Institutions

1,089

Shares Held

364M

Call Options Held

4.1M

Put Options Held

3.65M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $28.2B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account

Schonfeld Strategic Advisors LLC Dexcom Inc Transaction History